Tvardi Therapeutics's top three insider shareholders as of August 04, 2026 are Shaheen Wirk (Director, 439.19K shares), Wallace L Jr Hall (Director, 246.76K shares), Derek T Chalmers (President Ceo, 82.62K shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Derek T Chalmers | President Ceo | 82,617 | 0 | 09 Sep, 2021 |
| Harrison M Jr Bains | - | 4,787 | 0 | 05 Jun, 2023 |
| Martin Vogelbaum | - | 34,251 | 0 | 06 Jun, 2024 |
| Ryan D Maynard | Chief Financial Officer | 668 | 0 | 12 Feb, 2024 |
| Frederique Ph.D. Menzaghi | Chief Scientific Off,Svp Rd | 13,937 | 0 | 05 Feb, 2024 |
| Jeffrey L. Ives | - | 16,540 | 0 | 06 Jun, 2024 |
| Helen M Boudreau | - | 12,554 | 0 | 06 Jun, 2024 |
| Scott Terrillion | Sec'Y; Chief Compliance G.C. | 7,190 | 0 | 04 Mar, 2025 |
| Christopher Posner | President And Ceo | 13,109 | 0 | 04 Mar, 2025 |
| Wallace L Jr Hall | - | 0 | 246,756 | 02 May, 2025 |
| Richard Makara | Vp, Head Of Accting;Controller | 1,132 | 0 | 16 Jun, 2022 |
| Moltke Lisa Von | - | 15,251 | 0 | 06 Jun, 2024 |
| Thomas Charles Reilly | Chief Financial Officer | 3,151 | 0 | 04 Mar, 2022 |
| Shaheen Wirk | - | 0 | 439,194 | 02 May, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 29 Jan, 2026 | Avi Daniel Conn | Employee Stock Option (right to buy) | A | 45,000 | $0.00 | 45,000 | D | A |
| 29 Jan, 2026 | John Saewook M.D. Kauh | Employee Stock Option (right to buy) | A | 45,000 | $0.00 | 45,000 | D | A |
| 29 Jan, 2026 | Stephen Paul O'Brien | Employee Stock Option (right to buy) | A | 15,000 | $0.00 | 15,000 | D | A |
| 29 Jan, 2026 | Imran Nizamudin Alibhai | Employee Stock Option (right to buy) | A | 115,000 | $0.00 | 115,000 | D | A |
| 16 Dec, 2025 | John Saewook M.D. Kauh | Employee Stock Option (right to buy) | A | 17,500 | $0.00 | 17,500 | D | A |
| 16 Dec, 2025 | Avi Daniel Conn | Employee Stock Option (right to buy) | A | 17,500 | $0.00 | 17,500 | D | A |
| 16 Dec, 2025 | Imran Nizamudin Alibhai | Employee Stock Option (right to buy) | A | 47,500 | $0.00 | 47,500 | D | A |
| 16 Dec, 2025 | Stephen Paul O'Brien | Employee Stock Option (right to buy) | A | 4,000 | $0.00 | 4,000 | D | A |
| 07 Jul, 2025 | Samuel David Tweardy | Common Stock | D | 315,658 | $0.00 | 0 | I | J |
| 07 Jul, 2025 | Samuel David Tweardy | Common Stock | D | 315,658 | $0.00 | 0 | I | J |
| 07 Jul, 2025 | Samuel David Tweardy | Common Stock | D | 315,658 | $0.00 | 0 | I | J |
| 07 Jul, 2025 | Samuel David Tweardy | Common Stock | D | 315,658 | $0.00 | 0 | I | J |
| 07 Jul, 2025 | Samuel David Tweardy | Common Stock | D | 315,658 | $0.00 | 0 | I | J |
| 07 Jul, 2025 | Samuel David Tweardy | Common Stock | D | 315,658 | $0.00 | 0 | I | J |
| 15 Apr, 2025 | Shaheen Wirk | Common Stock | A | 176,030 | - | 176,030 | I | A |
| 15 Apr, 2025 | Shaheen Wirk | Common Stock | A | 176,030 | - | 176,030 | I | A |
| 15 Apr, 2025 | Shaheen Wirk | Common Stock | A | 176,030 | - | 176,030 | I | A |
| 15 Apr, 2025 | Wallace L Jr Hall | Common Stock | A | 44,712 | - | 44,712 | I | A |
| 15 Apr, 2025 | Shaheen Wirk | Common Stock | A | 263,164 | - | 263,164 | I | A |
| 15 Apr, 2025 | Shaheen Wirk | Common Stock | A | 263,164 | - | 263,164 | I | A |